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Cell replacement therapy is a promising avenue into the investigation and treatment of Parkinson’s disease 
(PD), and in some cases, significant long-term motor improvements have been demonstrated. The main source 
of donor tissue is the human fetal ventral mesencephalon (FVM), which consists of a mixed neuronal popula-
tion, and its heterogeneity likely contributes to the inconsistent outcome observed in clinical trials. Therefore, 
detailed knowledge about the neuronal subpopulations in the VM seems essential for successful cell transplan-
tation. Interestingly, it has been reported that some tyrosine hydroxylase-positive (TH+) neurons in the VM 
of adult rats and in cultured midbrain-derived neuroblasts coexpress additional neurotransmitters. Thus, the 
present study investigated, by means of colocalization analyses, the possible expression of GABA or serotonin 
in TH+ neurons. For that purpose, both fetal rat and human dissociated, organotypic and neurosphere FVM cul-
tures as well as an animal model of PD were investigated. In dissociated rat FVM cultures, approximately 30% 
of the TH+ neurons coexpressed serotonin, while no colocalization with GABA was observed. Interestingly, 
coexpression of TH and serotonin was found to be dependent on the time in culture, the plating density, and the 
exposure to neurotrophic factors, that is, higher cell densities and treatment with brain-derived neurotrophic 
factor resulted in a significantly reduced coexpression rate. Notably, even though approximately 30% of the 
dopaminergic neurons in the donor tissue coexpressed serotonin, no colocalization could be detected in grafts 
1 month after intrastriatal transplantation into hemiparkinsonian rats. In conclusion, a significant and suscep-
tible subpopulation of dopaminergic neurons in FVM tissues coexpresses serotonin. This might have potential 
implications for the future selection and handling of cells prior to transplantation in PD.
Key words: Human; Tyrosine hydroxylase (TH); 5-Hydroxytryptamine (5HT); Cell transplantation;  
Parkinsonian rats
INTRODUCTION
Increasing efforts have been made in the field of 
dopaminergic cell replacement as a therapeutic strategy 
for Parkinson’s disease (PD). At present, the fetal ven-
tral mesencephalic (FVM) tissue is still considered the 
“gold standard” for cell transplantation approaches in 
PD. Despite encouraging long-term clinical improve-
ments that have been reported for several patients up to 
20 years after fetal VM transplantation1, this technique is 
far from being considered an established clinical inter-
vention. Indeed, the controversial outcome of the dif-
ferent studies addressing the efficacy of fetal midbrain 
dopaminergic cell transplantation for PD patients empha-
sized the necessity to define standardized tissue selec-
tion, collection, storage, and implantation procedures2–11. 
In particular, a detailed cellular characterization of the 
graft tissue and more knowledge on the development of 
the different neuronal subpopulations present in these 
tissues are essential for a safe and effective outcome of 
cell transplantation for PD patients. Indeed, it is known 
that FVM tissue grafts consist of a mixture of different 
neuronal cell types. Beside tyrosine hydroxylase-positive 
(TH+) dopaminergic neurons, serotonin, g-aminobutyric 
acid (GABA), enkephalin, and substance P-containing 
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neurons also have been shown to be present in FVM tis-
sue grafts12–16. In fact, it has been suggested that such 
heterogeneity likely accounts for the variable outcome 
seen among groups of grafted patients17–19. The content 
of dopaminergic and serotonergic cells assumes a spe-
cial relevance in the framework of cell transplantation, 
as the first has the potential to antagonize and the latter 
has the capacity to promote the development of graft- 
induced dyskinesia20–22. Thus, improvement of current cell 
transplantation protocols relies also on interventions that 
might concomitantly optimize the yield of dopaminergic 
neurons and reduce the level of serotonergic neurons in 
grafts for transplantation23,24. Despite the known impor-
tance of graft cell content, a detailed characterization 
of the tissue grafts employed in clinical and preclinical 
settings is still missing. Above all, the phenotypic signa-
ture of the neurons and the mechanisms that might steer 
their fate remain to be defined. Thus, a broader definition 
of the expression profile of critical phenotypic markers 
might provide insights into the field of transplantation. 
Hence, the present study aimed at assessing potential 
coexpression of dopaminergic neurons with GABAergic 




Pregnant Wistar rats were purchased from Janvier 
Labs (Le Genest-Saint-Isle, France) and housed at 12-h 
light–dark cycle with food and water ad libitum. All 
experiments were carried out in the light phase and in 
accordance with the guidelines of the Animal Research 
Ethics Committee of the Canton Bern, Switzerland, and 
the University of Bern Animal Care and Use Committee, 
Switzerland (Study Nos. 89/05 and 6/12).
Human Tissue
All experiments were carried out in accordance with 
the ethics committee of the Medical Faculty of the 
University of Bern and the ethics committee of the State 
Bern, Switzerland (Study No. 181/07). Written consent 
was given by the women seeking abortion.
Preparation and Culture of Rat Organotypic Fetal 
Ventral Mesencephalic Cultures
Cell cultures from embryonic day 14 (E14) VM were 
prepared as described previously25. In brief, pregnant 
Wistar rats were deeply anesthetized using gas inhalation 
(4.5%–5% isoflurane, 75% N2O, 20% O2) followed by 
an intraperitoneal (IP) injection of a mix of ketamine 
(Narketan; 120 mg/kg; Vetoquinol, Ittigen, Switzerland) 
and xylazine (Xylapan; 20 mg/kg; Vetoquinol). The fetuses 
were removed by cesarean section, and the FVM was iso-
lated under a stereoscopic microscope. For preparation 
of organotypic cultures, that is, free-floating roller tube 
(FFRT) cultures, the FVM explants (2 mm ´  1.5 mm ´  
1 mm in size) were cut into four equally sized quadrants 
and transferred into gas-permeable conical plastic tubes 
(BD Falcon, Allschwil, Switzerland) supplied with 
1 ml of culture medium. The medium consisted of 55% 
Dulbecco’s modified Eagle’s medium (DMEM; Thermo 
Fisher Scientific, Reinach, Switzerland), 32.5% Hank’s 
balanced salt solution (HBSS; Thermo Fisher Scientific), 
1.5% glucose, 10% fetal calf serum (FCS; GIBCO), 1% 
0.01 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES; Merck, Zug, Switzerland), and 1% antibi-
otics–antimycotics (streptomycin, 10,000 µg/ml; penicil-
lin, 10,000 U/ml; and amphotericin B, 25 µg/ml; Thermo 
Fisher Scientific). The tubes were placed in a rotating 
roller drum (1 rev/min) placed in an incubator at 37°C 
in a 5% CO2 atmosphere25,26. The medium was changed 
after 2 days in vitro (DIV) and then every other day. At 
DIV8, the four FVM FFRT cultures originally derived 
from one fetal brain were pooled, washed twice in 0.1 M 
phosphate-buffered saline (PBS; pH 7.4), and either fixed 
in 4% paraformaldehyde (PFA; Merck) in PBS for 1 h 
and processed for histology or used for transplantation, 
as described below. Cultures for histology were cut at 
20 µm on a cryostat and mounted on Superfrost glass 
slides (Thermo Fisher Scientific).
Preparation and Culture of Rat Neurospheres
For the preparation of neurospheres, the FVM explants 
were cut into equally large pieces, mechanically dissoci-
ated, and transferred into uncoated six-well plates. For the 
first 7 days, the cultures were placed in 2 ml of medium 
consisting of DMEM/F12 with L-glutamine (Invitrogen, 
Reinach, Switzerland), 15 mM HEPES, 0.3% glucose 
containing 1% N2 supplement (100x; GIBCO), epider-
mal growth factor (EGF; 20 ng/ml; Promega, Dübendorf, 
Switzerland), and basic fibroblast growth factor (bFGF; 
20 ng/ml; Promega) to proliferate. Thereafter, neuro-
spheres were collected and transferred into 24-well plates 
with precoated poly-L-lysine (0.1 mg/ml, in 0.15 M 
sodium borate buffer, pH 8.3) glass coverslips that were 
filled with the same medium as used for FVM FFRT cul-
tures for another 14 days to differentiate the cells. At the 
end of the experimental period, the cultures were washed 
twice with ice-cold HBSS and fixed in 4% PFA in PBS 
for 30 min and processed for histology.
Preparation and Culture of Rat Dissociated Fetal 
Ventral Mesencephalic Cultures
The FVM explants were mechanically dissociated as 
previously described25 and plated at different densities 
into wells with precoated poly-L-lysine glass coverslips 
that were filled with the same medium as used for FVM 
FFRT cultures. The plating densities were 0.25, 0.5, 
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0.8, and 1.25 FVM per well (corresponding to 50 ´  103, 
100 ´  103, 160 ´  103, and 250 ´  103 cells/cm2, respectively). 
The cultures were incubated at 37°C in a 95% air/5% CO2 
humidified atmosphere, and the medium was changed at 
DIV2 and then every other day. The culture wells were 
randomly assigned to the different treatment groups, that 
is, control or brain-derived neurotrophic factor (BDNF; 
100 ng/ml; Promega). After DIV2, DIV5, or DIV8, the 
cultures were fixed in 4% PFA in PBS for 20 min and pro-
cessed for histology.
Preparation and Culture of Human Organotypic Fetal 
Ventral Mesencephalic Cultures
The embryonic age of the specimen was 9.1 to 10 weeks 
after conception (n = 4) for the analyses as determined by 
the method of Evtouchenko et al.27. The FFRT cultures 
were prepared from FVM derived from aborted human 
fetuses using the protocol described in detail previously28,29. 
In brief, the FVM tissue was dissected out and subdivided 
into equally sized pieces. Each piece was then placed into 
conical tubes supplied with 1 ml of medium and then 
transferred in a slowly (1 rev/min) rotating roller drum 
placed in an incubator at 37°C in a 5% CO2 atmosphere. 
The medium was identical to the one used for rat FVM 
FFRT cultures as described above and was changed every 
second day. At DIV8, the cultures from one embryo were 
pooled, washed twice in ice-cold HBSS, and fixed for 
1 h in 4% PFA in PBS. Cultures were cut on a cryostat 
at 20 µm and mounted on Superfrost glass slides and 
used for histology, as described below.
Preparation and Culture of Human Neurospheres
The human FVM neurospheres were prepared from 
FVM derived from aborted human fetuses, as described 
above. The embryonic age of the specimen (n = 4) was 
7.4, 8.0, 10.3, and 10.5 weeks after conception. The 
FVM tissue was cut into small equally large pieces, 
mechanically dissociated, and transferred into uncoated 
six-well plates. For the first 7 days, the cultures were 
placed in 2 ml of medium consisting of DMEM/F12 with 
L-glutamine, 15 mM HEPES, 0.3% glucose containing 
2% B27 supplement (50×; GIBCO), EGF (20 ng/ml), 
and bFGF (10 ng/ml) to proliferate. Thereafter, cultures 
were treated in the same way as for rat neurosphere cul-
tures and processed for histology.
Hemiparkinsonian Rats, Transplantation Surgery, 
and Perfusion
Female Wistar rats (Janvier Labs), weighing 180–
220 g, were anesthetized with gas inhalation (4.5%–5% 
isoflurane, 75% N2O, 20% O2) followed by an IP injection 
of a mixture of ketamine (75 mg/kg) and xylazine (5 mg/
kg) and a subcutaneous (SC) injection of buprenorphine 
(0.5 mg/kg; Reckitt Benckiser, Wallisellen, Switzerland) 
30 min before the surgical intervention. Subsequently, 
the rats were placed in a stereoscopic frame (Kopf instru-
ments, Tujunga, CA, USA) on a heating pad. The lesions 
were performed as previously described30,31. In brief, ani-
mals received an injection of 4 µl of 6-hydroxydopamine 
(6-OHDA, 32 mM; Sigma-Aldrich Chemie, Buchs, 
Switzerland) into the right striatum through a small burr 
hole created in the skull. The injection was performed 
over 6 min using a 10-µl Hamilton (Reno, NV, USA) 
microsyringe. The following coordinates in relation to 
the bregma (Paxinos Watson rat brain atlas) were used: 
1.0 mm posterior, 3.0 mm lateral, and 5.0 mm ventral to 
the dura; the incisor bar was set at 0.0 mm.
Five months after the 6-OHDA lesions, rats were 
anesthetized as described above. The rats were mounted 
on a stereoscopic frame on a heating pad, and each rat 
received a transplant consisting of four FVM cultures 
(corresponding to one FVM) grown for 8 DIV. The four 
FVM cultures were loaded on a 20-gauge spinal needle 
(Nihon Unisys, Tokyo, Japan) and injected into the right 
striatum of the rats as previously described26. The fol-
lowing coordinates in relation to the bregma (Paxinos 
Watson rat brain atlas) were used: 1.0 mm posterior, 
2.7 mm lateral, and 4.5 mm ventral to the dura; the inci-
sor bar was set at 0.0 mm. After injection, the needle was 
slowly retracted (1 mm/min).
One month after the transplantation, the animals 
were anesthetized using gas inhalation (4.5%–5% isoflu-
rane, 75% N2O, 20% O2) followed by an IP injection of 
a mixture of ketamine (75 mg/kg) and xylazine (5 mg/
kg). Just prior to opening the thorax, the animals received 
an IP injection of fentanyl (0.005 mg/kg; Janssen-Cilag, 
Zug, Switzerland). The rats were transcardially perfused 
with ice-cold 0.1 M PBS (pH 7.4) containing heparin 
(1,000 I.E./100 ml; NOVO Nordisk, Zürich, Switzerland) 
followed by 4% PFA in 0.1 M PBS. Immediately there-
after, the brains were removed and placed in the same 
fixative overnight and then placed in a cryoprotective of 
10% sucrose–PBS solution for at least 48 h30,31. The brains 
were cut on a cryostat in 30-µm-thick sections and moun-
ted on Superfrost™ (Thermo Fisher Scientific) slides30,31.
Immunohistochemistry
Dissociated cell cultures, neurospheres, FVM FFRT 
sections, and brain sections were washed in PBS and 
preincubated for 1 h in PBS containing 0.1% Triton 
X-100 (Sigma-Aldrich Chemie) and 10% horse serum 
(Thermo Fisher Scientific). After a brief wash in PBS, 
they were incubated overnight at 4°C with primary anti-
bodies [mouse monoclonal anti-TH, 1:1,000 (Millipore, 
Zug, Switzerland); rabbit polyclonal anti-TH, 1:1,000 
(Pel Freez Biologicals, Rogers, AR, USA); mouse mono-
clonal anti-5-hydroxytryptamine (5HT), 1:100 (Agilent 
Technologies, Basel, Switzerland); rabbit polyclonal 
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anti-GABA, 1:5,000 (Sigma-Aldrich Chemie); guinea 
pig polyclonal anti-serotonin transporter (SERT), 
1:2,000 (Thermo Fisher Scientific); mouse monoclonal 
anti-tryptophan hydroxylase (TrpH), 1:100 (Thermo 
Fischer Scientific)] diluted in PBS containing 0.1% 
Triton X-100 and 2.5% horse serum. Subsequent to 
washes in PBS, the cultures and slides were incubated 
for 2 h with fluorescently labeled antibodies (Alexa 
Fluor donkey anti-mouse 488 nm; Alexa Fluor donkey 
anti-rabbit 594 nm; Alexa Fluor goat anti-mouse 532 nm; 
Alexa Fluor donkey anti-guinea-pig 488 nm; 1:250; 
Molecular Probes, Reinach, Switzerland) and a fluores-
cent dye for detection of the cell nuclei (Hoechst 33352; 
1:10,000; Invitrogen). Cultures and sections were then 
washed in PBS and mounted in 0.1 M PBS containing 
50% glycerol.
Histological Analyses
All quantitative analyses were performed by a researcher 
blinded to the treatment groups. Immunoreactive cells in 
dissociated cultures were counted in 10% of the glass 
slide surface in a randomized way using a 10´ magnifi-
cation, as previously described25. Only cells with a dis-
tinct immunoreactivity and a clear neuronal shape were 
counted under a microscope (Olympus DP72; Olympus 
Schweiz AG, Volketswil, Switzerland) equipped with a 
motorized stage that was connected to a digital camera 
(Olympus Schweiz AG).
To assess the colocalization of different markers, six 
randomly chosen visual fields in each culture were taken, 
and the ones containing both phenotypes [4.8 ± 0.1 fields 
per culture; mean ± standard error of the mean (SEM); 
lower 95% confidence interval (CI): 4.3, upper 95% CI: 
5.3] were analyzed at a magnification of 40´ using the 
same microscope (culture time experiments: n = 12–14, 
three independent experiments; plating density experi-
ments: n = 6–17, three independent experiments; BDNF 
treatment experiments: n = 8–12, two independent experi-
ments; rat midbrain neurospheres: n = 2 embryos; human 
FVM FFRT cultures: n = 4 embryos; human midbrain neu-
rospheres: n = 4 embryos; FVM FFRT transplants: n = 4).
Statistical Evaluation
Statistical analysis of cell densities was performed 
using a commercially available software package (Graph 
Pad Prism 6, La Jolla, CA, USA). To compare group 
means of several groups, one-way analysis of variance 
(ANOVA) followed by Bonferroni’s multiple compari-
son test was used. Statistical significance of two groups 
only was assessed by two-tailed unpaired t-test, and the 
statistical significance level was set at p £ 0.05. Data are 
presented as mean ± SEM.
RESULTS
Expression of Tyrosine Hydroxylase and Serotonin 
in Organotypic E14 Rat Ventral Mesencephalic 
Cultures and in Rat Midbrain Neurospheres
We first explored the presence of serotonergic neurons 
in rat organotypic FVM FFRT cultures that are typically 
employed as graft tissue in animal models of cell trans-
plantation for PD26,31. Notably, we have observed that 
Figure 1. Coexpression of serotonin and tyrosine hydroxylase in rat ventral mesencephalic organotypic cultures and in rat neurospheres. 
Representative microphotographs showing double immunofluorescence stainings for the serotonergic marker 5-hydroxytryptamine (5HT; 
green) and the dopaminergic marker tyrosine hydroxylase (TH; red) in rat organotypic ventral mesencephalic free-floating roller tube cul-
tures grown for 8 days in vitro (A) and neurospheres cultured for 7 days under expansion (proliferative) conditions and 14 days under dif-
ferentiation conditions (B). Note the colocalization of 5HT and TH (arrowheads). Scale bars: 200 µm (A), 100 µm (B), 20 µm (insets).
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a subpopulation of 5HT immunoreactive (-ir) neurons 
colocalized with the dopaminergic marker TH in cultures 
grown for 8 days (Fig. 1A). Likewise, we detected 5HT+ 
cells colocalizing with TH in neurons sprouting from rat 
FVM neurosphere cultures subjected to differentiation 
(Fig. 1B).
Expression of Tyrosine Hydroxylase, Serotonergic 
Markers, and GABA in Dissociated E14 Rat Ventral 
Mesencephalic Cultures
These findings prompted us for a detailed character-
ization of the phenotypic nature of these TH-ir neurons. 
For this purpose, we assessed the expression of neuronal 
markers in dissociated E14 rat FVM cultures. In line 
with the results obtained for the organotypic FVM FFRT 
cultures, we observed that a subpopulation of TH-ir neu-
rons also expressed 5HT. In contrast, no coexpression of 
GABA in TH-ir neurons was detected (Fig. 2). Notably, 
the finding that all 5HT-ir cells also expressed the rate-
limiting enzyme TrpH as well as the SERT confirmed the 
serotonergic classification of these neurons. Consistent 
with the results described above, a subpopulation of the 
TrpH and SERT+ neurons also expressed TH (Fig. 3).
Effects of Culture Time on the Colocalization Rate 
of TH+ and 5HT+ Neurons in Dissociated E14 Rat 
Ventral Mesencephalic Cultures
We initially examined the TH and 5HT expression 
profile in our dissociated FVM cultures depending on 
the time in culture. The density of the whole TH-ir cell 
population was found to steadily decline from DIV2 to 
DIV8 (15.7 ± 1.0, 13.5 ± 0.7, and 10.8 ± 1.0 cells/mm2 for 
DIV2, DIV5, and DIV8, respectively) (Fig. 4A), resulting 
in a significant reduction in TH-ir cell density at DIV8 
( p < 0.0001 vs. DIV2) (Fig. 4A). In contrast, the number 
of 5HT-ir neurons displayed a transient but significant 
increase at DIV5 (5.5 ± 0.4, 8.1 ± 0.6, and 4.9 ± 0.4 cells/
mm2 for DIV2, DIV5, and DIV8, respectively; p = 0.03 
for DIV5 vs. DIV8) (Fig. 4A). When we analyzed cell 
densities of the subpopulation of the TH-ir neurons not 
expressing 5HT, we detected a significant drop already 
at DIV5 (13.2 ± 1.0, 8.6 ± 0.5, and 8.3 ± 0.8 cells/mm2 
for DIV2, DIV5, and DIV8, respectively; p = 0.0002 
and p < 0.0001 for DIV5 and DIV8 vs. DIV2) (Fig. 4B). 
Interestingly, the density of 5HT-ir cells negative for 
TH did not vary throughout the culture period (3.0 ± 0.5, 
3.2 ± 0.5, and 2.4 ± 0.4 cells/mm2 for DIV2, DIV5, and 
DIV8, respectively) (Fig. 4B).
As a consequence of these observations, the densi-
ties of cells expressing both TH and 5HT almost dou-
bled from DIV2 to DIV5 (2.5 ± 0.6 and 4.8 ± 0.5 cells/
mm2, respectively; p = 0.01 vs. DIV2) and returned to the 
initial level at DIV8 (2.5 ± 0.5 cells/mm2; p = 0.009 vs. 
DIV5) (Fig. 4C). When we analyzed the percentage of 
all TH-ir cells that coexpress 5HT, we detected a sig-
nificant increase at DIV5 and DIV8 compared to DIV2 
(12.9 ± 2.5%, 36.5 ± 3.9%, and 30.3 ± 5.8% at DIV2, 
DIV5, and DIV8, respectively; p = 0.003 and p = 0.03 
for DIV5 and DIV8 vs. DIV2) (Fig. 5A). A similar trend 
for a higher percentage at DIV5 compared to DIV2 
was observed for the 5HT-ir cells coexpressing TH, 
but the differences did not reach statistical significance 
Figure 2. Coexpression of tyrosine hydroxylase and serotonin in rat ventral mesencephalic dissociated cultures and lack of colocaliza-
tion with g-aminobutyric acid (GABA). Representative microphotographs illustrating double immunofluorescence stainings for the 
dopaminergic marker [tyrosine hydroxylase (TH); red upper row and green lower row] and the serotonin [5-hydroxytryptamine (5HT); 
green) or the GABAergic marker (GABA; red) in rat dissociated ventral mesencephalic cultures grown for 8 days in vitro. Note the 
colocalization of TH and 5HT (arrows) but not with GABA (arrowheads). Scale bar: 100 mm.
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(47.4 ± 10.4%, 63.8 ± 6.1%, and 47.6 ± 8.2% at DIV2, 
DIV5, and DIV8, respectively) (Fig. 5B).
Effects of Plating Density on the Colocalization Rate 
of TH+ Neurons With 5HT and 5HT+ Neurons With TH 
in Dissociated E14 Rat Ventral Mesencephalic Cultures
We next reasoned whether the plating density might 
influence the TH-ir and 5HT-ir colocalization rates. 
Accordingly, dissociated FVM cell preparations were 
plated at densities corresponding to 0.25, 0.5, 0.8, and 
1.25 embryos per well (e) and analyzed at DIV8. In 
this set of experiments, the percentage of TH-ir cells 
coexpressing 5HT progressively declined with increas-
ing plating density (53.3 ± 9.0%, 35.0 ± 5.7%, 8.8 ± 4.6%, 
and 0.9 ± 0.9% for 0.25e, 0.5e, 0.8e, and 1.25e, respec-
tively; p = 0.0001 and p = 0.0002 for 0.5e and 0.8e vs. 
0.25e, p = 0.002 and p = 0.003 for 0.8e and 1.25e vs. 0.5e) 
(Fig. 6A). Similarly, the percentage of 5HT-ir neurons 
coexpressing TH was significantly lower at higher plat-
ing densities compared to low cell densities (74.6 ± 8.9%, 
52.7 ± 7.3%, 14.0 ± 5.5%, and 4.8 ± 4.8% for 0.25e, 0.5e, 
0.8e, and 1.25e, respectively; p < 0.0001 for 0.5e and 0.8e 
vs. 0.25e; p = 0.0002 and p = 0.0006 for 0.8e and 1.25e vs. 
0.5e) (Fig. 6B).
Figure 3. Coexpression of different serotonergic markers with tyrosine hydroxylase in rat ventral mesencephalic dissociated cultures. 
Representative microphotographs showing double immunofluorescence stainings for the serotonergic marker 5-hydroxytryptamine 
(5HT; red) and tryptophan hydroxylase (TrpH; green; row A) and TrpH (green) with the dopaminergic marker tyrosine hydroxylase 
(TH; red; row C) as well as double immunofluorescence stainings for 5HT (red) and the serotonin transporter (SERT; green; row B) 
and SERT (green) with TH (red; row D). Stainings were performed in rat dissociated ventral mesencephalic cultures grown for 8 days 
in vitro. Note that all TrpH and SERT+ cells also expressed 5HT, and some colocalized with TH (arrowheads) but not all (arrow). Scale 
bar: 100 µm.
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Effects of BDNF Treatment on Colocalization Rate 
of TH+ Neurons With 5HT and 5HT+ Neurons With TH 
in Dissociated E14 Rat Ventral Mesencephalic Cultures
Based on these results, we sought to verify the hypoth-
esis that neurotrophic factors, such as BDNF, might 
influence the TH and 5HT expression pattern in the dis-
sociated FVM cultures. Overall, in the control cultures, 
the percentages of TH-ir neurons coexpressing 5HT and 
of 5HT-ir neurons coexpressing TH were consistent with 
the results described above (Fig. 5). At DIV2 (Fig. 7A 
and B) and DIV5 (Fig. 7C and D), FVM cultures grown 
in the presence of BDNF did not show substantial dif-
ferences in the colocalization rates compared to controls. 
Figure 4. Quantitative analysis of the effect of time in culture 
on the cell densities of tyrosine hydroxylase and serotonin+ neu-
rons. The cell densities of tyrosine hydroxylase immunoreac-
tive (TH-ir) and 5-hydroxytryptamine immunoreactive (5HT-ir) 
neurons (A), of TH-ir and 5HT-ir neurons without coexpression 
of the other marker (B), and of colocalizing neurons (C) were 
measured at day in vitro (DIV) 2, DIV5, and DIV8 in rat ven-
tral mesencephalic dissociated cultures with plating densities 
of 0.5 embryos per well. Note the decline of TH-ir cells over 
time as well as the peak of colocalizing cells at DIV5. Data 
are expressed as cells/mm2 and given as mean + standard error 
of the mean (SEM); n = 12–14 from three independent experi-
ments. *p < 0.05.
Figure 5. Quantitative analysis of the effects of time in culture 
on the colocalization rate of tyrosine hydroxylase and serotonin. 
The colocalization rate of tyrosine hydroxylase-positive (TH+) 
cells also expressing 5-hydroxytryptamine (5HT) (A) and of 
5HT+ cells also expressing TH (B) is presented over the period 
of 2, 5, and 8 days in vitro (DIV) in rat ventral mesencephalic 
dissociated cultures at 0.5 embryos per well plating densities. 
Note the increase in TH+ cells colocalizing with 5HT at DIV5 
and DIV8 (A), whereas the colocalization rate of 5HT+ cells 
also expressing TH remains consistently high (B). Data are 
expressed as percentage of TH+ or 5HT+ cells, respectively, and 
given as mean + standard error of the mean (SEM); n = 12–14 
from three independent experiments. *p < 0.05 versus DIV2.
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In contrast, supplementation of BDNF for a prolonged 
time period, that is, DIV8, resulted in a significant reduc-
tion of TH-ir neurons coexpressing 5HT compared to 
controls (12.2 ± 3.5% vs. 25.3 ± 4.2%; p = 0.03) (Fig. 7E) 
and 5HT-ir neurons coexpressing TH (23.1 ± 6.6% vs. 
47.2 ± 7.4%; p = 0.03) (Fig. 7F).
Expression of Tyrosine Hydroxylase and Serotonin 
in Organotypic Human Ventral Mesencephalic 
Cultures and in Human Midbrain Neurospheres
In order to investigate whether the observed colocal-
ization of 5HT in TH-ir neurons derived from rat fetal 
tissues is conserved from rats to humans, we performed 
FVM FFRT and neurosphere cultures of human embryonic 
origin. Indeed, the immunohistochemical analyses of 
FVM FFRT cultures and differentiated neurospheres evi-
denced a distinct coexpression of 5HT as well as TrpH in 
a subpopulation of TH-ir neurons (Fig. 8A–C).
Expression of TH+ and 5HT+ Neurons in Transplanted 
Rat Organotypic Ventral Mesencephalic Grafts
Finally, we assessed for the presence of 5HT-ir neurons 
in intrastriatal FVM tissue grafts in the 6-OHDA animal 
model of PD. While the immunohistochemical analyses 
of the transplants revealed the presence of numerous 
TH-ir neurons as well as 5HT-ir neurons, no coexpres-
sion of 5HT was detected in any of the TH+ neurons in the 
grafts 1 month after transplantation (Fig. 9).
DISCUSSION
Improving our knowledge about the tissue employed 
for transplantation in PD is of critical importance for the 
success of this intervention. Despite the advances in neu-
robiology, a deep characterization of FVM tissue is still 
missing. The present work provides important insights 
into the content of FVM cultures of rat and human origin 
by demonstrating that dopaminergic neurons coexpress the 
specific serotonergic markers 5HT, TrpH, and SERT but 
fail to display colocalization with GABA. Furthermore, 
we observed that the colocalization of TH and 5HT is 
influenced by culture conditions such as the plating den-
sity, the time in culture, and the treatment with BDNF.
The well-established notion that FVM tissue consists 
of a mosaic of different cell populations including sero-
tonergic cells has significant relevance in transplantation 
medicine. This is because the presence of serotonergic 
cells in the graft has been associated with drawbacks 
of FVM transplantation, such as graft-induced dyskine-
sias20–22. Moreover, it has been described that the rela-
tionship of the densities between serotonergic neurons 
and dopaminergic neurons in the grafts plays an impor-
tant role for long-term efficacy of FVM transplants20–22. 
Hence, there are increasing efforts carried out to obtain a 
defined population of dopaminergic cells such as by phe-
notypic sorting from dissociated mesencephalic tissue23,24 
or through strategies of somatic cell reprogramming32. 
The results of the present study, however, point to the 
idea that in E14 FVM, the dopaminergic and serotoner-
gic cell populations cannot be univocally distinguished. 
The dual dopaminergic/serotonergic identity of a pool 
of TH-ir neurons is supported by the coexpression of 
TH with TrpH and SERT. The presence of this partially 
overlapping phenotype and its dynamic changes in cul-
ture indicate that at this developmental stage, the cells of 
FVM tissue display still a high degree of plasticity. These 
findings thus implicate that the fate of a fraction of the 
mesencephalic cells could eventually be steered in order 
to increase the pool of transplantable dopaminergic cells. 
Figure 6. Quantitative analysis of the effects of cell densi-
ties on colocalization rate of tyrosine hydroxylase and sero-
tonin. Effects of plating densities on the colocalization rate 
of tyrosine hydroxylase-positive (TH+) cells coexpressing 
5-hydroxytryptamine (5HT) (A) or 5HT+ cells coexpressing TH 
(B) in rat dissociated ventral mesencephalic cultures grown for 
8 days in vitro at 0.25, 0.5, 0.8, and 1.25 embryos (e) per well 
density. Note the density-dependent decline for both colocaliza-
tion rates (A, B). Data are expressed as percentage of TH+ or 
5HT+ cells, respectively, and given as mean + standard error of 
the mean (SEM); n = 6–17 from three independent experiments. 
*p < 0.05 versus 0.25e, #p < 0.05 versus 0.5e.
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Our results are in line with the close interconnection of 
the dopaminergic and serotonergic cell ontogenesis, dur-
ing which they reside rostral and caudal to the midbrain–
hindbrain boundary, respectively. For their development, 
both cell populations depend closely on the secretion of 
specific factors to initiate their proper phenotype33,34.
In the present work, we have not addressed whether 
at the time of the analyses the cells were terminally 
differentiated or still responsive to fate determinants. 
However, the effects of time in culture and plating density 
on the colocalization rate strongly suggest that indeed the 
phenotype of FVM neurons is still influenced by envi-
ronmental factors. While the progressive decrease in the 
number of TH+ neurons in dissociated cultures over time 
is in line with previous reports35–37, the high rate of dop-
aminergic cells coexpressing 5HT reaching approximately 
Figure 7. Quantitative analysis of the effects of BDNF treatment on colocalization rate of tyrosine hydroxylase and serotonin. Effects 
of brain-derived neurotrophic factor (BDNF) treatment on the colocalization rate of tyrosine hydroxylase-positive (TH+) cells coexpress-
ing 5-hydroxytryptamine (5HT) (A, C, E) or 5HT+ cells coexpressing TH (B, D, F) in rat dissociated ventral mesencephalic cultures 
grown for 2 (A, B), 5 (C, D), and 8 (E, F) days in vitro at plating densities of 0.5 embryos per well. Note that BDNF treatment reduced 
the colocalization rate of both TH+ cells expressing also 5HT and 5HT+ cells coexpressing TH at day in vitro 8. Moreover, fewer TH+ 
cells coexpress 5HT than 5HT+ neurons express TH. Data are expressed as percentage of TH+ or 5HT+ cells, respectively, and given as 
mean + standard error of the mean (SEM); n = 8–12 from two independent experiments. *p < 0.05 versus corresponding controls.
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Figure 8. Coexpression of serotonin and tyrosine hydroxylase in human ventral mesencephalic organotypic cultures and in human neu-
rospheres. Representative microphotographs of double immunofluorescence stainings for the serotonergic marker 5-hydroxytryptamine 
(5HT; green) and the dopaminergic marker tyrosine hydroxylase (TH; red) in human organotypic ventral mesencephalic free-floating roller 
tube cultures grown for 8 days in vitro (A) and human neurospheres cultured for 7 days under expansion (proliferative) conditions and 
14 days under differentiation conditions (B). Note the colocalization of 5HT and TH (arrowheads). Moreover, double immunofluorescence 
stainings for the serotonergic marker tryptophan hydroxylase (TrpH; green) and the dopaminergic marker TH (red) in human neurosphere 
cultures demonstrated colocalization of the two markers (arrow head) (C). Scale bars: 200 µm (A, C), 100 µm (B), 20 µm (insets).
Figure 9. No colocalization of serotonin and tyrosine hydroxylase in grafts of rat organotypic ventral mesencephalic tissue. 
Representative microphotographs of double immunofluorescence staining for the serotonergic marker 5-hydroxytryptamine (5HT; 
green, arrows) and the dopaminergic marker tyrosine hydroxylase (TH; red, arrowheads) in rat ventral mesencephalic free-floating 
roller tube grafts transplanted into the striatum of 6-hydroxydopamine (6-OHDA)-lesioned rats. The immunohistochemical analysis 
was conducted 1 month after the transplantation. Note that none of the TH+ neurons coexpresses 5HT. Scale bar: 50 µm.
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30% at DIV5–DIV8 is a novel and noteworthy finding. 
Currently, the reason of a transient increase in 5HT expres-
sion in dopaminergic cells at DIV5 is not known. In con-
trast to culture time, cell density negatively affected the 
coexpression rate of TH+ and 5HT+ cells. This observation 
is likely associated with enhanced survival of TH+ cells 
with increasing cell density in combination with a steady 
number of 5HT+ cells. This is in line with previously pub-
lished reports, demonstrating that higher plating densi-
ties result in a less pronounced decline in dopaminergic 
neurons after 8 days in culture38 and induce an increase 
in TH mRNA, TH protein, and dopamine release39. 
Although in the framework of cell transplantation these 
results suggest that culturing mesencephalic cells at high 
density prior to grafting would be optimal for a superior 
yield of dopaminergic neurons, likely these advantages 
cannot be fully exploited given the difficulties to bring 
such cultured cells in suspension. Notably, however, we 
provide further evidence of the benefit of graft pretreat-
ment with neurotrophic factors, which goes beyond an 
augmented number of TH+ cells and improved graft func-
tion in animal models of PD26,40,41. Indeed, the observed 
significantly reduced number of TH+ cells coexpress-
ing 5HT after BDNF treatment may hint to a possible 
decrease in serotonergic cell-dependent side effects after 
grafting. That different growth factors can influence the 
phenotype of dopaminergic and serotonergic neurons is 
also highlighted by a study demonstrating that the fate of 
neural progenitors in FVM aggregates changed toward a 
dopaminergic instead of a serotonergic phenotype when 
fibroblast growth factor 4 (FGF-4) was lacking34.
The lack of any colocalization of serotonergic and 
dopaminergic markers in grafts of rat organotypic FVM 
tissue 1 month after transplantation in the striatum of par-
kinsonian rats is another important finding of the pres-
ent work. Given earlier observations that most implanted 
embryonic dopamine neurons die within 1 to 2 weeks 
after transplantation7,42–45, one may speculate that a specific 
vulnerability of the TH/5HT-ir cell subpopulation might 
account for the loss of colocalization of these markers in 
the graft. Alternatively, the absence of TH/5HT-ir cells in 
the graft might be the result of neuronal-type fate deci-
sion processes and/or commitment to a specific neuronal 
fate program elicited by in vivo differentiating cues. 
In this context, an intriguing aspect of the neuron-type 
specification involves the neurotransmitter switch, which 
occurs also in the adult brain as a result of the orches-
trated interaction between intrinsic genetic determinants 
by trophic factors and signals delivered by morphoge-
netic proteins, neurotransmitters, and local electric activ-
ity46. Accordingly, it has been reported that serotonergic 
neurons derived from progenitors in the raphe nucleus 
might be induced to switch to a cholinergic phenotype 
by ciliary neurotrophic factor (CNTF) and leukemia 
inhibitory factor (LIF)47. Further studies are needed to 
evaluate the underlying dynamics of fate determination 
in the colocalizing cells in the graft over broader time 
periods after transplantation. Analysis in the first weeks 
after transplantation might provide relevant information 
as this is the time period in which most of the grafted 
cells die and the fibers grow out into the host tissue44. 
Moreover, it would be of high interest to investigate the 
coexpression of TH and 5HT in grafts of postmortem PD 
patients, as their host brain environment might have a 
critical effect, different to the one in the rat brain. In this 
respect, it is important to note that the present study is 
based particularly on the analysis of phenotypic traits. A 
more comprehensive investigation involving additional 
neuronal parameters would help to classify the identity of 
the cells in our cultures.
In conclusion, our findings illustrate that a subpopu-
lation of cultured FVM dopaminergic neurons expresses 
serotonergic markers. Notably, we provide in vitro evi-
dence of the TH and 5HT coexpression independent of 
the culture system analyzed, that is, being detectable in 
dissociated cells, explants, and neurospheres undergoing 
differentiation. Although we have not yet explored how 
to govern the differentiation programs of these cells, the 
present work may have an impact on studies investigat-
ing the generation of dopaminergic neurons from neu-
ronal precursors/progenitors and highlights the potential 
of neurotrophic factors on emerging neuronal phenotypes 
in the developing midbrain.
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